×
戻る Agenda
SLS01 ICH 30th Anniversary: Summary of 30 Years and Future Prospects with the Role of Japan
Session Chair(s)
Kazuhiko Mori, PhD, MSc
Former Executive Director
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Toshiyoshi Tominaga, PhD
Life Science Department, Advisor
SunFlare Co., Ltd, Japan
Speaker(s)
Lenita Lindström, LLM
European Commission, Belgium
ICH Assembly Chair and Senior Expert, European Commission
Celia Lourenco, PhD
Health Canada, Canada
Director General, Biologic and Radiopharmaceutical Drugs Directorate, HPFB
Nobumasa Nakashima
Cabinet Office, Japan
Health Policy Director, National Healthcare Policy Secretariat
Hironobu Hiyoshi, PhD
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Member of the ICH Management Committee and of the Assembly
Theresa Mullin, PhD
FDA, United States
Associate Center Director - CDER
Naoyuki Yasuda, MSc
Pharmaceuticals and Medical Devices Agency, Japan